Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) Net Margin: 2014-2025

Historic Net Margin for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to 3.08%.

  • Surgery Partners' Net Margin rose 22500.0% to 3.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.71%, marking a year-over-year decrease of 28400.0%. This contributed to the annual value of 0.4% for FY2024, which is 8400.0% up from last year.
  • Latest data reveals that Surgery Partners reported Net Margin of 3.08% as of Q3 2025, which was up 22500.0% from 5.43% recorded in Q2 2025.
  • Surgery Partners' 5-year Net Margin high stood at 8.64% for Q2 2023, and its period low was 6.11% during Q1 2021.
  • In the last 5 years, Surgery Partners' Net Margin had a median value of 0.18% in 2023 and averaged 0.38%.
  • As far as peak fluctuations go, Surgery Partners' Net Margin soared by 116300bps in 2023, and later plummeted by -117400bps in 2024.
  • Over the past 5 years, Surgery Partners' Net Margin (Quarter) stood at 0.02% in 2021, then crashed by -20093bps to 3.31% in 2022, then soared by 292bps to 6.35% in 2023, then tumbled by -185bps to 5.39% in 2024, then soared by 157bps to 3.08% in 2025.
  • Its Net Margin was 3.08% in Q3 2025, compared to 5.43% in Q2 2025 and 0.04% in Q1 2025.